These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 13641966)

  • 1. Observations on the psychotogenic effect of N-N diethyltryptamine, a new tryptamine derivative.
    BOSZORMENYI Z; DER P; NAGY T
    J Ment Sci; 1959 Jan; 105(438):171-81. PubMed ID: 13641966
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of antiserotonin on the experimental psychosis induced by dimethyltryptamine.
    SAI-HALASZ A
    Experientia; 1962 Mar; 18():137-8. PubMed ID: 14496041
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral effects of N,N-diethyltryptamine: absence of antagonism by xylamidine tosylate.
    Winter JC
    J Pharmacol Exp Ther; 1969 Sep; 169(1):7-16. PubMed ID: 5306645
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects on amine oxidase of substances which antagonize 5-hydroxytryptamine more than tryptamine on the rat fundus strip.
    BARLOW RB
    Br J Pharmacol Chemother; 1961 Apr; 16(2):153-62. PubMed ID: 13687054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lilliputian hallucinations in the functional psychoses.
    LEWIS DJ
    Can Psychiatr Assoc J; 1961 Aug; 6():177-201. PubMed ID: 13761697
    [No Abstract]   [Full Text] [Related]  

  • 6. [Facial expression in hallucinations in experimental and other psychoses].
    HEIMANN H
    Schweiz Arch Neurol Neurochir Psychiatr; 1963; 92():226-31. PubMed ID: 13953397
    [No Abstract]   [Full Text] [Related]  

  • 7. Significance of the thalamus in psychoses; with reference to hallucinations and delusions.
    BATEMAN JF; PAPEZ JW
    J Clin Exp Psychopathol; 1951; 12(1):89-103. PubMed ID: 24540728
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analysis of the interaction of peripheral serotonin antagonists with tryptamine and N,N-dimethyltryptamine on rabbit electrocorticograms].
    Fediaeva-Basova LP
    Farmakol Toksikol; 1972 Jul; 35(4):414-8. PubMed ID: 5077140
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives.
    CERLETTI A; ROTHLIN E
    Nature; 1955 Oct; 176(4486):785-6. PubMed ID: 13265830
    [No Abstract]   [Full Text] [Related]  

  • 10. [Delusions and hallucinations. Their mutual relations taken as the point of departure for a clarification of the concept of psychotic being].
    VERBEEK E
    Ned Tijdschr Psychol; 1963 Mar; 18():103-30. PubMed ID: 13996700
    [No Abstract]   [Full Text] [Related]  

  • 11. [OLFACTORY HALLUCINATIONS IN MENTAL PATIENTS].
    AMICO G; DEMAIO D; FAGGIOLI L
    Rass Neuropsichiatr; 1963; 17():446-65. PubMed ID: 14200909
    [No Abstract]   [Full Text] [Related]  

  • 12. A fluorescence test for serotonin and other tryptamines.
    JEPSON JB; STEVENS BJ
    Nature; 1953 Oct; 172(4382):772. PubMed ID: 13111187
    [No Abstract]   [Full Text] [Related]  

  • 13. 2-Aryl tryptamines: selective high-affinity antagonists for the h5-HT2A receptor.
    Stevenson GI; Smith AL; Lewis S; Michie SG; Neduvelil JG; Patel S; Marwood R; Patel S; Castro JL
    Bioorg Med Chem Lett; 2000 Dec; 10(24):2697-9. PubMed ID: 11133071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ganser syndrome in psychoses.
    LIEBERMAN AA
    J Nerv Ment Dis; 1954; 120(1-2):10-6. PubMed ID: 13212396
    [No Abstract]   [Full Text] [Related]  

  • 15. The activation of serotonin receptors by tryptamine induces hyperinsulinemia in mice.
    Yamada J; Sugimoto Y; Kimura I; Takeuchi N; Horisaka K
    Eur J Pharmacol; 1990 Jun; 181(3):319-22. PubMed ID: 2200694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COMPARATIVE STUDY OF HALLUCINATIONS.
    MOTT RH; SMALL IF; ANDERSON JM
    Arch Gen Psychiatry; 1965 Jun; 12():595-601. PubMed ID: 14286889
    [No Abstract]   [Full Text] [Related]  

  • 17. An inquiry into eidetic imagery with particular reference to visual hallucinations.
    SALTZMAN SS; MACHOVER S
    Am J Psychiatry; 1952 Apr; 108(10):740-8. PubMed ID: 14914901
    [No Abstract]   [Full Text] [Related]  

  • 18. Tryptamine, a substrate for the serotonin transporter in human platelets, modifies the dissociation kinetics of [3H]imipramine binding: possible allosteric interaction.
    Segonzac A; Raisman R; Tateishi T; Schoemaker H; Hicks PE; Langer SZ
    J Neurochem; 1985 Feb; 44(2):349-56. PubMed ID: 3871227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of N,N'-diethyltryptamine and U-22,394A, a new tryptamine derivative.
    Tang AH; Uhlinger BJ; Schroeder LA
    Arch Int Pharmacodyn Ther; 1968 Nov; 176(1):74-85. PubMed ID: 5709792
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional interaction between serotonin-S2 and dopamine-D2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine.
    Awouters F; Niemegeers CJ; Megens AA; Janssen PA
    J Pharmacol Exp Ther; 1990 Sep; 254(3):945-51. PubMed ID: 1697623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.